Observational Study of Safety of Flu Cell Culture Derived Adjuvanted Swine Origin A (H1N1) Pandemic Subunit Vaccine

Clinical trial NCT01037855 · COMPLETED

Trial details

NCT number: NCT01037855
Sponsor: Novartis Vaccines
Status: COMPLETED
Study type: OBSERVATIONAL

Novel Influenza A (H1N1)A New Flu Virus of Swine Origin

Start date: 2009-12-01
Primary completion: 2010-06-01
Enrollment: 4028

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.